Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Citi
Accenture
Fish and Richardson
Baxter
Teva
Federal Trade Commission
McKinsey
Queensland Health
Julphar

Generated: December 11, 2017

DrugPatentWatch Database Preview

Lek Pharm Company Profile

« Back to Dashboard

What is the competitive landscape for LEK PHARM, and what generic and branded alternatives to LEK PHARM drugs are available?

LEK PHARM has three approved drugs.

There are two tentative approvals on LEK PHARM drugs.

Summary for Lek Pharm

US Patents:0
Tradenames:2
Ingredients:2
NDAs:3
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Patent Submitted Product Substance Delist Req. Exclusivity Expiration
Lek PharmACYCLOVIRacyclovirCAPSULE;ORAL074750-001Apr 22, 1997DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Lek PharmACYCLOVIRacyclovirTABLET;ORAL074658-001Apr 22, 1997DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Lek PharmBROMOCRIPTINE MESYLATEbromocriptine mesylateCAPSULE;ORAL075100-001Dec 10, 1998DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Lek PharmACYCLOVIRacyclovirTABLET;ORAL074658-002Apr 22, 1997DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Similar Applicant Names

Individual applicants are sometimes listed under multiple names.
Here is a list of applicants with similar names.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Citi
Moodys
QuintilesIMS
Chinese Patent Office
Daiichi Sankyo
Novartis
Farmers Insurance
Johnson and Johnson
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot